Jiangsu Coben Pharmaceutical Co., Ltd.

About Jiangsu Coben Pharmaceutical Co., Ltd.

Founded in 2005, Coben Group was designed and built according to GMP standard with a total area of 100,000㎡, a member of ZJMI Group-Global Fortune 500, Ranked No.270 in 2018.
Coben is specialized in developing and manufacturing of APIs and intermediates for various drugs. Main products include: Sofosbuvir, Tenofovir, Ticagrelor, Sacubitril, Voriconazole, Isavuconazole and their intermediates.

Certifications
  • CN
  • 2018
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
Pharmaceutical company
Primary activities
API Producer
Intermediates Manufacturer
Contact info
  • 168 Shanghai Road, Qidong life and health Industrial Park,, Jiangsu, China
Meet us at

CPHI & PMEC China 2024

Shanghai New International Expo Center
19 - 21 June 2024

Products from Jiangsu Coben Pharmaceutical Co., Ltd. (5)